Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Core Insights - Aclaris Therapeutics, Inc. is participating in the Piper Sandler 37th Annual Healthcare Conference in New York City on December 2, 2025, at 11:00 AM EST [1] - The company focuses on developing novel product candidates for immuno-inflammatory diseases [3] Company Overview - Aclaris Therapeutics is a clinical-stage biopharmaceutical company with a pipeline aimed at addressing the needs of patients suffering from immuno-inflammatory diseases who currently lack satisfactory treatment options [3] - The company boasts a multi-stage portfolio of product candidates supported by a robust research and development engine [3] Communication and Accessibility - A live and archived webcast of the conference participation will be available on Aclaris' website for at least 30 days [2]